This talk will examine the changes introduced by the new legislation on pharmacovigilance (Regulation 1235/2010 and Directive 2010/84) and the impact these changes have on pharmacovigilance obligations. 

Audience: 

 
 In-house lawyers 
• Non-UK private practitioners with pharma clients
• Patent attorneys
• Regulatory affairs professionals
• Pharmacovigilance professionals 
• Commercial managers 
• Compliance managers 
 

Speakers: 

David Dennis

Online Event